Rafaela Gomes da Silva Teixeira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rafaela Gomes da Silva Teixeira has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Calil Elias Junior
Universidade Federal do RIo de Janeiro - UFRJ
1 shared publication - Bruno Cotrim
Núcleo de Ciências Químicas, Instituto Federal do Rio de Janeiro, Rio de Janeiro 20270-021, RJ, Brazil
1 shared publication - Cristiano Gonçalves Ponte
Instituto Federal de Educação, Ciências e Tecnologia do Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication - Gabriel Fernandes de Andrade
Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos - Far Manguinhos, 21041-250, Rio de Janeiro, Brazil
1 shared publication - Gabriel Resende
Núcleo de Ciências Químicas, Instituto Federal do Rio de Janeiro, Rio de Janeiro 20270-021, RJ, Brazil
1 shared publication - Sabrina Calil-Elias
Universidade Federal Fluminense
1 shared publication
Latest Publications
- Open Access
- 21 February 2022
- Published by Universidade Federal do Rio Grande do Norte - UFRN in Revista Informação na Sociedade Contemporânea
- Vol. 6, e27214
Drugs and Infodemic
The first year of the COVID-19 pandemic brought critical scientific advances at speeds never seen before. The information from scientific studies won the world in news and social media. However, the spread of fake news provided an infodemic among a still unknown disease and no scientifically proven treatment. The present study aimed to evaluate the content and type of information on drugs indicated for the treatment of COVID-19 without scientific evidence in Brazilian social media. Two social media, Instagram and Twitter, were selected to search for drug information related to the prevention or treatment of COVID-19. The research was carried out using hashtags: #chloroquine, #hydroxychloroquine, #ivermectin, and #nitazoxanide for Portuguese publications in March 2020 and 2021. Descriptive statistic was used to present the quantitative data. In 2020, chloroquine was the drug with the highest number of publications in both social networks analyzed. The publications addressed the evidence of drug use and shortages, and the vast majority were considered correct information. While in 2021, ivermectin was the predominant drug cited on Instagram, while chloroquine was the most published on Twitter. Both drugs were related to “early treatment” and political and ideological content, classified as mostly disinformation. Thus, it is necessary to reinforce these social media guidelines to reduce the spread of health disinformation to the population. At the same time, health education in digital media is supported to ensure that the best information on management and care for COVID-19 reaches people and promotes their quality of life.
- 21 February 2022
- Published by Universidade Federal do Rio Grande do Norte - UFRN in Revista Informação na Sociedade Contemporânea
- Vol. 6, e27214
Open AccessDrugs and Infodemic
The first year of the COVID-19 pandemic brought critical scientific advances at speeds never seen before. The information from scientific studies won the world in news and social media. However, the spread of fake news provided an infodemic among a still unknown disease and no scientifically proven treatment. The present study aimed to evaluate the content and type of information on drugs indicated for the treatment of COVID-19 without scientific evidence in Brazilian social media. Two social media, Instagram and Twitter, were selected to search for drug information related to the prevention or treatment of COVID-19. The research was carried out using hashtags: #chloroquine, #hydroxychloroquine, #ivermectin, and #nitazoxanide for Portuguese publications in March 2020 and 2021. Descriptive statistic was used to present the quantitative data. In 2020, chloroquine was the drug with the highest number of publications in both social networks analyzed. The publications addressed the evidence of drug use and shortages, and the vast majority were considered correct information. While in 2021, ivermectin was the predominant drug cited on Instagram, while chloroquine was the most published on Twitter. Both drugs were related to “early treatment” and political and ideological content, classified as mostly disinformation. Thus, it is necessary to reinforce these social media guidelines to reduce the spread of health disinformation to the population. At the same time, health education in digital media is supported to ensure that the best information on management and care for COVID-19 reaches people and promotes their quality of life.
- Open Access
Microwave Assisted Synthesis of 4-Phenylquinazolin-2(1H)-one Derivatives that Inhibit Vasopressor Tonus in Rat Thoracic Aorta
Quinazolinones have pharmacological effects on vascular reactivity through different mechanisms. We synthesized 4-phenylquinazolin-2(1H)-one derivatives under microwave irradiation and tested them on the rat thoracic aorta. The prepared compounds 2a–2f were obtained in about 1 h with suitable yields (31–92%). All derivatives produced vasorelaxant effects with IC50 values ranging from 3.41 ± 0.65 µM to 39.72 ± 6.77 µM. Compounds 2c, 2e and 2f demonstrated the highest potency in endothelium-intact aorta rings (IC50 4.31 ± 0.90 µM, 4.94 ± 1.21 µM and 3.41 ± 0.65 µM respectively), and they achieved around 90% relaxation (30 μM). In aorta rings without an endothelium, the effect of compound 2f was abolished. Using the MTT assay to test for cell viability, only compound 2b induced cytotoxicity at the maximum concentration employed (30 µM). The results show that vasorelaxation by 4-phenylquinazolin-2(1H)-one derivatives might depend on the activation of a signalling pathway triggered by endothelium-derived factors.
Open AccessMicrowave Assisted Synthesis of 4-Phenylquinazolin-2(1H)-one Derivatives that Inhibit Vasopressor Tonus in Rat Thoracic Aorta
Quinazolinones have pharmacological effects on vascular reactivity through different mechanisms. We synthesized 4-phenylquinazolin-2(1H)-one derivatives under microwave irradiation and tested them on the rat thoracic aorta. The prepared compounds 2a–2f were obtained in about 1 h with suitable yields (31–92%). All derivatives produced vasorelaxant effects with IC50 values ranging from 3.41 ± 0.65 µM to 39.72 ± 6.77 µM. Compounds 2c, 2e and 2f demonstrated the highest potency in endothelium-intact aorta rings (IC50 4.31 ± 0.90 µM, 4.94 ± 1.21 µM and 3.41 ± 0.65 µM respectively), and they achieved around 90% relaxation (30 μM). In aorta rings without an endothelium, the effect of compound 2f was abolished. Using the MTT assay to test for cell viability, only compound 2b induced cytotoxicity at the maximum concentration employed (30 µM). The results show that vasorelaxation by 4-phenylquinazolin-2(1H)-one derivatives might depend on the activation of a signalling pathway triggered by endothelium-derived factors.